Dementia with Diabetes Market in the 7MM is expected to expand at a healthy growth rate by 2032, estimates DelveInsight

DelveInsight's "Dementia with Diabetes Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Dementia with Diabetes, historical and forecasted epidemiology as well as the Dementia with Diabetes market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Discover Key Insights into the Dementia with Diabetes Market with DelveInsight's In-Depth Report @ Dementia with Diabetes Market Size [https://www.delveinsight.com/sample-request/dementia-with-diabetes-market-forecast?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]

Key Takeaways from the Dementia with Diabetes Market Report

* In November 2024:- HiDO Technologies- Globally, >47M individuals live with dementia, with new incidence of 7.7M annually. Medication mismanagement is one of the most common and concerning risk factors in people with dementia (PwD), as it leads to undertreatment, emergency room visits, hospital admissions/readmissions, and serious adverse events. 3M older U.S. adults are admitted to nursing homes due to drug-related adherence problems with costs >$14B/year. Furthermore, 30% of hospital admissions of older adults are drug related with 11% attributed to medication non-adherence and 17% to adverse drug reactions.
* Alzheimer's disease is the most common type of dementia. Current estimates are that about 5.8 million people in the United States have Alzheimer's disease and related dementias, including 5.6 million aged 65 and older and about 200,000 under age 65 with younger-onset Alzheimer's (CDC, 2022).
* As per the study by Walters & Ikram (2019), vascular dementia is generally considered the second most common subtype of dementia, after Alzheimer disease, accounting for roughly 15% to 20% of dementia cases in North America and Europe.
* According to TREND-UK (2020), the prevalence of Type 2 diabetes and dementia increases in older people and both conditions are significantly increasing in numbers, with over 850,000 people with dementia and almost 3.7 million people with diabetes in the UK.
* As per the study by Takashi Ashada (2017), the survey of early-onset dementia was done in five prefectures and two cities in all parts of Japan from 2006 to 2008. The estimated number of patients per 100,000 in the 18-64-year-old population was 47.6.
* The leading Dementia With Diabetes Companies such as Novo Nordisk, Pfizer, EIP Pharma, Sun Pharma, Allyx Therapeutics, Bioxcel Therapeutics , and others
* PRomising Dementia With Diabetes Therapies such as Thiazolidinediones, Meglitinides, GLP-1 receptor agonists, DPP-4 inhibitors , and others

Stay ahead in the Dementia with Diabetes Therapeutics Market with DelveInsight's Strategic Report @ Dementia with Diabetes Market Outlook [https://www.delveinsight.com/sample-request/dementia-with-diabetes-market-forecast?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]

Dementia with Diabetes Epidemiology Segmentation in the 7MM

* Diagnosed Prevalent Cases of Dementia
* Age-specific Cases of Dementia
* Type-specific Cases of Dementia
* Treated Cases of Dementia With Diabetes
* Diagnosed Prevalent Cases of Dementia With Diabetes

Download the report to understand which factors are driving Dementia with Diabetes epidemiology trends @ Dementia with Diabetes Prevalence [https://www.delveinsight.com/sample-request/dementia-with-diabetes-market-forecast?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]

Dementia With Diabetes Unmet Needs

* Lack of epidemiological data
* Early detection and diagnosis
* Scarcity of approved therapies and challenges in treatment
* Integrated Care Approach
* Impact on quality of life

Dementia With Diabetes Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Dementia With Diabetes market or expected to get launched during the study period. The analysis covers Dementia With Diabetes market uptake by drugs, patient uptake by therapies, and sales of each drug. Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.

Get In-Depth Knowledge on Dementia with Diabetes Market Trends and Forecasts with DelveInsight @ Dementia with Diabetes Treatment Market [https://www.delveinsight.com/sample-request/dementia-with-diabetes-market-forecast?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]

Scope of the Dementia with Diabetes Market Report

* Coverage- 7MM
* Dementia with Diabetes Companies- Novo Nordisk, Pfizer, EIP Pharma, Sun Pharma, Allyx Therapeutics, Bioxcel Therapeutics, and others
* Dementia With Diabetes Therapies- Thiazolidinediones, Meglitinides, GLP-1 receptor agonists, DPP-4 inhibitors, and others
* Dementia with Diabetes Competitive Intelligence Analysis: SWOT analysis and Market entry strategies
* Dementia with Diabetes Unmet Needs, KOL's views, Analyst's views, Dementia with Diabetes Market Access and Reimbursement

Table of Content

1. Key Insights

2. Executive Summary of Dementia with Diabetes

3. Competitive Intelligence Analysis for Dementia with Diabetes

4. Dementia with Diabetes: Market Overview at a Glance

5. Dementia with Diabetes: Disease Background and Overview

6. Patient Journey

7. Dementia with Diabetes Epidemiology and Patient Population

8. Treatment Algorithm, Current Treatment, and Medical Practices

9. Dementia with Diabetes Unmet Needs

10. Key Endpoints of Dementia with Diabetes Treatment

11. Dementia with Diabetes Marketed Products

12. Dementia with Diabetes Emerging Therapies

13. Dementia with Diabetes: Seven Major Market Analysis

14. Attribute analysis

15. 7MM: Market Outlook

16. Access and Reimbursement Overview of Dementia with Diabetes

17. KOL Views

18. Market Drivers

19. Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

23. About DelveInsight

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=dementia-with-diabetes-market-in-the-7mm-is-expected-to-expand-at-a-healthy-growth-rate-by-2032-estimates-delveinsight]
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/case-study/in-licensing-opportunity



This release was published on openPR.